Evidence map›Paper›PMID 33230363›Full record

ArticleMammal review2021

Risk of human-to-wildlife transmission of SARS-CoV-2.

Sophie Gryseels, Luc De Bruyn, Ralf Gyselings, Sébastien Calvignac-Spencer, Fabian H Leendertz, Herwig Leirs

Open access · hybridAbstract read
In one paragraph

Article in Mammal review, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Drivers of bat researchers' intent to adopt field hygiene practices.Conservation biology : the journal of the Society for Conservation Biology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. SARS-CoV-2 Infection in Captive Hippos (Animals : an open access journal from MDPI · 2023
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Sophie GryseelsDepartment of Microbiology, Immunology and Transplantation Rega Institute, KU Leuven Herestraat 49 Leuven 3000 Belgium.ORCID https://orcid.org/0000-0002-4851-9384
Luc De BruynDepartment of Biology University of Antwerp Universiteitsplein 1 Antwerp 2610 Belgium.ORCID https://orcid.org/0000-0002-8968-8862
Ralf GyselingsResearch Institute for Nature and Forest (INBO) Havenlaan 88 Brussels 1000 Belgium.ORCID https://orcid.org/0000-0001-9147-5279
Sébastien Calvignac-SpencerRobert Koch Institute Nordufer 20 Berlin 13353 Germany.ORCID https://orcid.org/0000-0003-4834-0509
Fabian H LeendertzRobert Koch Institute Nordufer 20 Berlin 13353 Germany.ORCID https://orcid.org/0000-0002-2169-7375
Herwig LeirsDepartment of Biology University of Antwerp Universiteitsplein 1 Antwerp 2610 Belgium.ORCID https://orcid.org/0000-0002-7612-5024
Robert Koch Institute · DEUniversity of Antwerp · BEResearch Institute for Nature and Forest · BEUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been a long time since the world has experienced a pandemic with such a rapid devastating impact as the current COVID-19 pandemic. The causative agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is unusual in that it appears capable of infecting many different mammal species. As a significant proportion of people worldwide are infected with SARS-CoV-2 and may spread the infection unknowingly before symptoms occur or without any symptoms ever occurring, there is a non-negligible risk of humans spreading SARS-CoV-2 to wildlife, in particular to wild non-human mammals. Because of SARS-CoV-2's apparent evolutionary origins in bats and reports of humans transmitting the virus to pets and zoo animals, regulations for the prevention of human-to-animal transmission have so far focused mostly on these animal groups. We summarise recent studies and reports that show that a wide range of distantly related mammals are likely to be susceptible to SARS-CoV-2, and that susceptibility or resistance to the virus is, in general, not predictable, or only predictable to some extent, from phylogenetic proximity to known susceptible or resistant hosts. In the absence of solid evidence on the susceptibility and resistance to SARS-CoV-2 for each of the >6500 mammal species, we argue that sanitary precautions should be taken by humans interacting with any other mammal species in the wild. Preventing human-to-wildlife SARS-CoV-2 transmission is important to protect these animals (some of which are classed as threatened) from disease, but also to avoid establishment of novel SARS-CoV-2 reservoirs in wild mammals. The risk of repeated re-infection of humans from such a wildlife reservoir could severely hamper SARS-CoV-2 control efforts. Activities during which direct or indirect interaction with wild mammals may occur include wildlife research, conservation activities, forestry work, pest control, management of feral populations, ecological consultancy work, management of protected areas and natural environments, wildlife tourism and wildlife rehabilitation in animal shelters. During such activities, we recommend sanitary precautions, such as physical distancing, wearing face masks and gloves, and frequent decontamination, which are very similar to regulations currently imposed to prevent transmission among humans. We further recommend active surveillance of domestic and feral animals that could act as SARS-CoV-2 intermediate hosts between humans and wild mammals.

Indexed as

COVID‐19human‐to‐wildlife transmissionmammalsnovel reservoirprotective equipmentSARS‐CoV‐2wildlife

Identifiers

PMID33230363
PMCPMC7675675
OpenAlexW3023215995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.